Results 231 to 240 of about 9,263,948 (394)
Summary Clinical outcome after chimeric antigen receptor (CAR)‐T‐cell failure in large B‐cell lymphoma (LBCL) is dismal. Allogeneic stem cell transplantation (alloSCT) represents a potentially curative salvage for relapsed/refractory LBCL, although concerns remain regarding its feasibility and safety in patients exposed to CAR‐T and bispecific ...
Angelica Barone+10 more
wiley +1 more source
Observations on seasonal occurrence in lymphomas with proven or presumed infectious etiology. [PDF]
Anagnostopoulos I+6 more
europepmc +1 more source
Comparison of Fascin Expression in Anaplastic Large Cell Lymphoma and Hodgkin Disease [PDF]
Guang Fan+3 more
openalex +1 more source
Diffuse large B‐cell lymphoma is a heterogeneous and aggressive pathology. MicroRNAs, deregulated in patient tumours and blood, are promising non‐invasive predictive biomarkers for this pathology. We identified the circulating miR‐200c/421/324 signature both predictive of response to R‐CHOP and correlated with PFS.
Giulia Regazzo+15 more
wiley +1 more source
Risk-Stratified and Response-Adapted Therapy for Pediatric Hodgkin Lymphoma in Argentina: The GATLA Experience. [PDF]
Veron D+10 more
europepmc +1 more source
Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers
Paolo Fiumara+2 more
openalex +1 more source
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly) [PDF]
Veronika Ballová+14 more
openalex +1 more source
Hodgkin disease in the elderly. A registry‐based analysis
F. Erdkamp+4 more
semanticscholar +1 more source
Summary Immune effector cell‐associated neurotoxicity syndrome (ICANS)‐associated cognitive impairment is common in patients who receive chimeric antigen receptor T‐cell (CAR‐T) therapy. This study evaluated the utility of the clock drawing task (CDT) in detecting ICANS in patients with haematological cancers following CAR‐T therapy.
Christina Kazzi+22 more
wiley +1 more source